Biochemical characterization of a component in extracts of Viscum album enhancing human NK cytotoxicity
- PMID: 2708032
- DOI: 10.1016/0162-3109(89)90003-9
Biochemical characterization of a component in extracts of Viscum album enhancing human NK cytotoxicity
Abstract
Enhancement of human NK cytotoxicity in the presence of fresh Viscum album extract and some commercial V. album extracts Iscador correlated strictly with an increased formation of lytic effector cell/K562 tumor cell conjugates in the single-cell assay. Both activities were completely destroyed by pretreatment of V. album extracts with pectinase, hemicellulase, amyloglucosidase and alpha-glucosidase, but not with proteases and RNase, i.e., the activities are linked to a polysaccharide. The active component in V. album extract was non-dialysable at a molecular weight cutoff of 10,000. Inhibition of both activities was observed with D-galacturonic acid, poly-galacturonic acid and pectins. The site of galacturonic acid-specific interaction could be identified on the effector cells. The rate of effector cell/tumor cell conjugate formation in the presence of V. album extracts, as well as the abrogation of both activities by pretreatment of V. album extracts with exoglycosidases specific for sugars other than galacturonic acid indicated an action of the NK cytotoxicity-enhancing component on the basis of a bridging mechanism. However, no conclusive results could be obtained for the structural specificity of the site interacting with the target cells.
Similar articles
-
Chemical specificity of effector cell/tumor cell bridging by a Viscum album rhamnogalacturonan enhancing cytotoxicity of human NK cells.Immunopharmacology. 1990 Jan-Feb;19(1):69-77. doi: 10.1016/0162-3109(90)90028-d. Immunopharmacology. 1990. PMID: 2407685
-
Mediation of human NK-activity by components in extracts of Viscum album.Int J Immunopharmacol. 1987;9(2):199-209. doi: 10.1016/0192-0561(87)90095-6. Int J Immunopharmacol. 1987. PMID: 3583510
-
Activation of natural killer cell cytotoxicity of human blood monocytes by a low molecular weight component from viscum album extract.Arzneimittelforschung. 1989 Dec;39(12):1580-5. Arzneimittelforschung. 1989. PMID: 2624609
-
Immunomodulatory effects of Viscum album extracts on natural killer cells: review of clinical trials.Forsch Komplementmed. 2010 Apr;17(2):63-73. doi: 10.1159/000288702. Epub 2010 Mar 12. Forsch Komplementmed. 2010. PMID: 20484913 Review.
-
Recent studies on the anticancer activities of mistletoe (Viscum album) and its alkaloids.Oncology. 1986;43 Suppl 1:42-50. doi: 10.1159/000226419. Oncology. 1986. PMID: 3543783 Review.
Cited by
-
Phase II study of viscum fraxini-2 in patients with advanced hepatocellular carcinoma.Br J Cancer. 2004 Jan 12;90(1):65-9. doi: 10.1038/sj.bjc.6601463. Br J Cancer. 2004. PMID: 14710208 Free PMC article. Clinical Trial.
-
Influence of Viscum album preparations on the natural killer cell-mediated cytotoxicity of peripheral blood.Naturwissenschaften. 1989 Nov;76(11):530-1. doi: 10.1007/BF00374131. Naturwissenschaften. 1989. PMID: 2615845 No abstract available.
-
Mechanism of stimulation of human natural killer cytotoxicity by arabinogalactan from Larix occidentalis.Cancer Immunol Immunother. 1993;36(4):237-44. doi: 10.1007/BF01740905. Cancer Immunol Immunother. 1993. PMID: 8439987 Free PMC article.
-
A Viscum album oligosaccharide activating human natural cytotoxicity is an interferon gamma inducer.Cancer Immunol Immunother. 1990;32(4):221-7. doi: 10.1007/BF01741704. Cancer Immunol Immunother. 1990. PMID: 2124513 Free PMC article.
-
A Randomized Study on Postrelapse Disease-Free Survival with Adjuvant Mistletoe versus Oral Etoposide in Osteosarcoma Patients.Evid Based Complement Alternat Med. 2014;2014:210198. doi: 10.1155/2014/210198. Epub 2014 Mar 31. Evid Based Complement Alternat Med. 2014. PMID: 24803944 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources